Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Sep 27, 2024; 16(9): 2942-2952
Published online Sep 27, 2024. doi: 10.4240/wjgs.v16.i9.2942
Published online Sep 27, 2024. doi: 10.4240/wjgs.v16.i9.2942
Table 4 Multi-sequence prediction model results
| Test group | Training group | ||||
AUC (95%CI) | Sensitivity (%) | Specificity (%) | AUC (95%CI) | Sensitivity (%) | Specificity (%) | |
TIWI + CE-T1WI fs | 0.834 (0.736-0.922) | 70.4 | 85.2 | 0.917 (0.825-0.984) | 77.8 | 88.9 |
T2WIfs + CE-T1WI fs | 0.783 (0.661-0.893) | 73.9 | 73.0 | 0.866 (0.769-0.949) | 73.9 | 91.3 |
DWI + CE-T1WI fs | 0.796 (0.684-0.899) | 70.4 | 77.8 | 0.825 (0.714-0.917) | 70.8 | 79.2 |
T1WI + T2WIfs + DWI + CE-T1WI fs | 0.818 (0.727-0.897) | 60.0 | 77.1 | 0.770 (0.567-0.938) | 70.0 | 80.0 |
- Citation: Pan GH, Zhou F, Chen WB, Pan ZJ. Advancing gastrointestinal stromal tumor management: The role of imagomics features in precision risk assessment. World J Gastrointest Surg 2024; 16(9): 2942-2952
- URL: https://www.wjgnet.com/1948-9366/full/v16/i9/2942.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i9.2942